These initial experiments connect JNK-mediated signaling via Jun/FosL2 and TGFß signaling via Smad3 to maintain activation of Rho and MRTF, leading to non-canonical Hedgehog signaling in resistant BCC cells. Here, SMAD3 is linked to skin basal cell carcinoma.